meRfi®-GM
Alcohol-associated Liver Disease (ALD)
Welcome to meRfi-GM!
meRfi-GM provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Navigation
Contents
Alcohol-related liver disease (ALD) is a condition with few treatment options due to its complex pathogenesis.
Alcohol-associated Liver Disease (ALD) spectrum showing the progression of pathology and contributing factors that initiate disease onset and promote disease progression. Alcohol-associated Liver Disease (ALD) is characterized by chronic and/or excessive alcohol intake, which leads to steatosis, inflammation (i.e., alcoholic hepatitis) and [Liver Fibrosis / Cirrhosis](brain://v0wDqmafJUS7SD4b7yLCYA/LiverFibro…
References (Sources)
- 26—Epidemiology, Natural History, and Evaluation of Nonalcoholic Fatty Liver Disease
- Alcohol or Gut Microbiota: Who Is the Guilty?
- Bile acid-receptor TGR5 deficiency worsens liver injury in alcohol-fed mice by inducing intestinal microbiota dysbiosis
- Deficiency of intestinal mucin-2 ameliorates experimental alcoholic liver disease in mice
- Estimate of hepatocellular carcinoma incidence in patients with alcoholic cirrhosis
- Gut Microbiota, Cirrhosis, and Alcohol Regulate Bile Acid Metabolism in the Gut
- Intestinal permeability, microbial translocation, changes in duodenal and fecal microbiota, and their associations with alcoholic liver disease progression in humans